BOONE CAPITAL MANAGEMENT LLC
13F Reported Value
ⓘ$326.4M
Holdings
13
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
BOONE CAPITAL MANAGEMENT LLC disclosed 13 positions worth $326.4M in its Form 13F-HR for Q1 2026, led by $MIRM (Mirum Pharmaceuticals, Inc.) at 11.9% of the equity portfolio, followed by $IONS and $CI. During the quarter the fund opened 4 new positions and exited 6 — including a new stake in $TFX and a full exit from $NBIX. The portfolio is most concentrated in Healthcare (100.0% of disclosed assets). All figures are sourced directly from BOONE CAPITAL MANAGEMENT LLC’s Form 13F-HR filing with the SEC under CIK 1882053.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 32.7#2,252
Quality
$38.9M421,236 sh - 37.1#2,069
Quality
$37.6M500,522 sh - 66.8#499
Quality
$36.7M137,522 sh - —
Quality
$34.5M398,065 sh - 30.5
Quality
$33.3M278,792 sh - 74.1
Quality
$30.9M547,871 sh - 47.3
Quality
$23.8M631,193 sh - —
Quality
$21.7M110,101 sh - 66.8
Quality
$21.4M79,226 sh - 31.7
Quality
$17.0M228,829 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Mirum Pharmaceuticals, Inc.$MIRM | 32.7#2,252 | $38.9M | 421,236 |
 IONIS PHARMACEUTICALS INC$IONS | 37.1#2,069 | $37.6M | 500,522 |
 Cigna Group$CI | 66.8#499 | $36.7M | 137,522 |
 Medtronic plc$MDT | — | $34.5M | 398,065 |
 TELEFLEX INC$TFX | 30.5 | $33.3M | 278,792 |
 BIOMARIN PHARMACEUTICAL INC$BMRN | 74.1 | $30.9M | 547,871 |
 Guardian Pharmacy Services, Inc.$GRDN | 47.3 | $23.8M | 631,193 |
 ASTRAZENECA PLC$AZN | — | $21.7M | 110,101 |
 UNITEDHEALTH GROUP INC$UNH | 66.8 | $21.4M | 79,226 |
 BridgeBio Pharma, Inc.$BBIO | 31.7 | $17.0M | 228,829 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of BOONE CAPITAL MANAGEMENT LLC's 13 positions.
Showing top 10 of 13 holdings.
Sector Allocation
Healthcare
$326.4M
Full Holdings — BOONE CAPITAL MANAGEMENT LLC (Q1 2026)
All 13 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $MIRM | Mirum Pharmaceuticals, Inc. | $38.9M | 11.9% | +0% | 32.7 |
| 2 | $IONS | IONIS PHARMACEUTICALS INC | $37.6M | 11.5% | +20% | 37.1 |
| 3 | $CI | Cigna Group | $36.7M | 11.2% | +43% | 66.8 |
| 4 | $MDT | Medtronic plc | $34.5M | 10.6% | -7% | — |
| 5 | $TFX | TELEFLEX INC | $33.3M | 10.2% | NEW | 30.5 |
| 6 | $BMRN | BIOMARIN PHARMACEUTICAL INC | $30.9M | 9.5% | +33% | 74.1 |
| 7 | $GRDN | Guardian Pharmacy Services, Inc. | $23.8M | 7.3% | NEW | 47.3 |
| 8 | $AZN | ASTRAZENECA PLC | $21.7M | 6.7% | -50% | — |
| 9 | $UNH | UNITEDHEALTH GROUP INC | $21.4M | 6.6% | +28% | 66.8 |
| 10 | $BBIO | BridgeBio Pharma, Inc. | $17.0M | 5.2% | +24% | 31.7 |
| 11 |  $AVNS | AVANOS MEDICAL, INC. | $16.6M | 5.1% | NEW | 31.3 |
| 12 |  $KOD | Kodiak Sciences Inc. | $10.7M | 3.3% | -44% | — |
| 13 |  $TENX | TENAX THERAPEUTICS, INC. | $3.2M | 1.0% | NEW | — |
New Positions (4)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for BOONE CAPITAL MANAGEMENT LLC including:
Track BOONE CAPITAL MANAGEMENT LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for BOONE CAPITAL MANAGEMENT LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: BOONE CAPITAL MANAGEMENT LLC
13F Pro is an AI hedge fund tracker and stock research platform. For BOONE CAPITAL MANAGEMENT LLC (SEC CIK: 1882053), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in BOONE CAPITAL MANAGEMENT LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.